Volgen
Salvatore De Rosa
Salvatore De Rosa
Magna Graecia University
Geverifieerd e-mailadres voor unicz.it
Titel
Geciteerd door
Geciteerd door
Jaar
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
77402017
Circulating microRNAs in patients with coronary artery disease
S Fichtlscherer, S De Rosa, H Fox, T Schwietz, A Fischer, C Liebetrau, ...
Circulation research 107 (5), 677-684, 2010
14852010
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
S De Rosa, C Spaccarotella, C Basso, MP Calabrò, A Curcio, PP Filardi, ...
European heart journal 41 (22), 2083-2088, 2020
10242020
Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links
S De Rosa, B Arcidiacono, E Chiefari, A Brunetti, C Indolfi, DP Foti
Frontiers in endocrinology 9, 334630, 2018
3522018
Transcoronary concentration gradients of circulating microRNAs
S De Rosa, S Fichtlscherer, R Lehmann, B Assmus, S Dimmeler, ...
Circulation 124 (18), 1936-1944, 2011
3232011
Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries
G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ...
Atherosclerosis 285, 135-146, 2019
3032019
Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature
D Erkapic, S De Rosa, A Kelava, R Lehmann, S Fichtlscherer, ...
Journal of cardiovascular electrophysiology 23 (4), 391-397, 2012
2842012
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
P Cirillo, P Golino, P Calabro, G Calì, M Ragni, S De Rosa, G Cimmino, ...
Cardiovascular research 68 (1), 47-55, 2005
2182005
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ...
European heart journal 43 (7), e17-e25, 2022
1862022
Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR
NM Van Mieghem, M Unverdorben, C Hengstenberg, H Moellmann, ...
New England Journal of Medicine 385 (23), 2150-2160, 2021
1752021
Patient selection and timing of continuous renal replacement therapy
M Ostermann, M Joannidis, A Pani, M Floris, S De Rosa, JA Kellum, ...
Blood purification 42 (3), 224-237, 2016
1692016
MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis
C Eyileten, Z Wicik, S De Rosa, D Mirowska-Guzel, A Soplinska, C Indolfi, ...
Cells 7 (12), 249, 2018
1532018
Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review
J Pordzik, D Jakubik, J Jarosz-Popek, Z Wicik, C Eyileten, S De Rosa, ...
Cardiovascular diabetology 18, 1-19, 2019
1302019
Emerging role of microRNAs in cardiovascular diseases
S De Rosa, A Curcio, C Indolfi
Circulation Journal 78 (3), 567-575, 2014
1272014
MicroRNAs for restenosis and thrombosis after vascular injury
C Gareri, S De Rosa, C Indolfi
Circulation research 118 (7), 1170-1184, 2016
1262016
Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis
J Sabatino, S De Rosa, G Di Salvo, C Indolfi
PloS one 15 (8), e0237131, 2020
1202020
The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no …
K Hemmann, M Sirotina, S De Rosa, JR Ehrlich, H Fox, J Weber, A Moritz, ...
Interactive cardiovascular and thoracic surgery 17 (2), 359-364, 2013
1172013
Pre-angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease: primary results of the international multicenter iFR …
Y Kikuta, CM Cook, ASP Sharp, P Salinas, Y Kawase, Y Shiono, ...
JACC: Cardiovascular interventions 11 (8), 757-767, 2018
1142018
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study
L De Luca, S Leonardi, C Cavallini, D Lucci, G Musumeci, R Caporale, ...
European Heart Journal: Acute Cardiovascular Care 4 (5), 441-452, 2015
1132015
Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach?
SD Rosa, P Cirillo, A Paglia, L Sasso, VD Palma, M Chiariello
Current vascular pharmacology 8 (2), 259-275, 2010
1102010
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20